Filing Details
- Accession Number:
- 0001140361-23-010166
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-03 21:00:30
- Reporting Period:
- 2023-03-01
- Accepted Time:
- 2023-03-03 21:00:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1635088 | Roivant Sciences Ltd. | ROIV | Pharmaceutical Preparations (2834) | 981173944 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1885841 | Richard Pulik | C/O Roivant Sciences Ltd. 7Th Floor, 50 Broadway London X0 SW1H 0DB | Cfo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Disposition | 2023-03-01 | 1,912 | $8.08 | 223,347 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") previously granted to the reporting person. This sale was effected pursuant to a "sell to cover" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person.
- Includes Common Shares purchased under the Company's Employee Stock Purchase Plan.
Billionaire Hedge Funds
